These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 12167961

  • 1. Clopidogrel in interventional cardiology: questions answered and questions remaining.
    Nikhil JY, Radhakrishnan S, Paradiso-Hardy FL, Cohen EA.
    Can J Cardiol; 2002 Jul; 18(7):739-48. PubMed ID: 12167961
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. What is the role for improved long-term antiplatelet therapy after percutaneous coronary intervention?
    Steinhubl S, Berger P.
    Am Heart J; 2003 Jun; 145(6):971-8. PubMed ID: 12796751
    [Abstract] [Full Text] [Related]

  • 4. [Optimal platelet inhibition after coronary stent implantation. Current status].
    Silber S, Hoffmeister HM, Bode C.
    Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
    [Abstract] [Full Text] [Related]

  • 5. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after coronary stent implantation.
    Juergens CP, Wong AM, Leung DY, Lowe HC, Lo S, Fernandes C, Newland EF, Hopkins AP.
    Am Heart J; 2004 Apr; 147(4):E15. PubMed ID: 15077098
    [Abstract] [Full Text] [Related]

  • 6. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis.
    O'Donoghue M, Antman EM, Braunwald E, Murphy SA, Steg PG, Finkelstein A, Penny WF, Fridrich V, McCabe CH, Sabatine MS, Wiviott SD.
    J Am Coll Cardiol; 2009 Aug 18; 54(8):678-85. PubMed ID: 19679245
    [Abstract] [Full Text] [Related]

  • 7. Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent.
    Wang ZJ, Zhou YJ, Liu YY, Yu M, Shi DM, Zhao YX, Guo YH, Cheng WJ, Jia de A, Cao Z, Nie B, Ge HL, Yang SW, Yan ZX.
    Thromb Res; 2009 May 18; 124(1):46-51. PubMed ID: 19041120
    [Abstract] [Full Text] [Related]

  • 8. Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation.
    Wolak A, Amit G, Cafri C, Gilutz H, Ilia R, Zahger D.
    Int J Cardiol; 2005 Sep 01; 103(3):293-7. PubMed ID: 16098392
    [Abstract] [Full Text] [Related]

  • 9. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance.
    Lev EI, Patel RT, Maresh KJ, Guthikonda S, Granada J, DeLao T, Bray PF, Kleiman NS.
    J Am Coll Cardiol; 2006 Jan 03; 47(1):27-33. PubMed ID: 16386660
    [Abstract] [Full Text] [Related]

  • 10. Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement.
    Hochholzer W, Trenk D, Bestehorn HP, Fischer B, Valina CM, Ferenc M, Gick M, Caputo A, Büttner HJ, Neumann FJ.
    J Am Coll Cardiol; 2006 Nov 07; 48(9):1742-50. PubMed ID: 17084243
    [Abstract] [Full Text] [Related]

  • 11. Optimizing platelet P2Y12 inhibition for patients undergoing PCI.
    Steinhubl S, Roe MT.
    Cardiovasc Drug Rev; 2007 Nov 07; 25(2):188-203. PubMed ID: 17614940
    [Abstract] [Full Text] [Related]

  • 12. High-dose clopidogrel loading in percutaneous coronary intervention.
    Longstreth KL, Wertz JR.
    Ann Pharmacother; 2005 May 07; 39(5):918-22. PubMed ID: 15811910
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Randomized trial comparing 600- with 300-mg loading dose of clopidogrel in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: results of the Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary intervention in Acute coronary Lesions (PRACTICAL) Trial.
    Yong G, Rankin J, Ferguson L, Thom J, French J, Brieger D, Chew DP, Dick R, Eccleston D, Hockings B, Walters D, Whelan A, Eikelboom JW.
    Am Heart J; 2009 Jan 07; 157(1):60.e1-9. PubMed ID: 19081397
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
    Tanzilli G, Greco C, Pelliccia F, Pasceri V, Barillà F, Paravati V, Pannitteri G, Gaudio C, Mangieri E.
    Am J Cardiol; 2009 Nov 15; 104(10):1357-61. PubMed ID: 19892050
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of clopidogrel pretreatment before percutaneous coronary intervention with and without glycoprotein IIb/IIIa inhibitor use.
    Sabatine MS, Hamdalla HN, Mehta SR, Fox KA, Topol EJ, Steinhubl SR, Cannon CP.
    Am Heart J; 2008 May 15; 155(5):910-7. PubMed ID: 18440341
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy.
    Pride YB, Wiviott SD, Buros JL, Zorkun C, Tariq MU, Antman EM, Braunwald E, Gibson CM, TIMI Study Group.
    Am Heart J; 2009 Sep 15; 158(3):e21-6. PubMed ID: 19699846
    [Abstract] [Full Text] [Related]

  • 19. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.
    Serebruany VL, Malinin AI, Jerome SD, Lowry DR, Morgan AW, Sane DC, Tanguay JF, Steinhubl SR, O'connor CM.
    Am Heart J; 2003 Oct 15; 146(4):713-20. PubMed ID: 14564328
    [Abstract] [Full Text] [Related]

  • 20. A high maintenance dose of clopidogrel improves short-term clinical outcomes in patients with acute coronary syndrome undergoing drug-eluting stent implantation.
    Han YL, Wang B, Li Y, Xu K, Wang SL, Jing QM, Wang ZL, Wang DM, Ma YY, Wang G.
    Chin Med J (Engl); 2009 Apr 05; 122(7):793-7. PubMed ID: 19493391
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.